All In Biotech

Drug Trial Radar · NCT00679523

Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail

An Open-Label, Rising Multiple-Dose, Multi-Center Study to Evaluate the Safety and Efficacy of Topically Applied AN2690 5.0% and 7.5% Solution for the Treatment of Adult Subjects With Onychomycosis of the Great Toenail

Last checked: Nov 20, 2026Latest source record: Nov 14, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Nov 2005

Primary completion

Feb 2007

Study completion Feb 2007

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
May 19, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to determine the safety and efficacy of 5.0% and 7.5% AN2690 Solution in the treatment of distal, subungual onychomycosis of the great target toenail.

Conditions

  • Onychomycosis

Interventions

  • AN2690 Solution, 5.0%Drug

    Once daily application for 180 days

  • AN2690 Solution, 7.5%Drug

    Once daily application for 180 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. A calculated endpoint of treatment response at Day 180 comprised of the ISGA, clear nail growth and fungal culture resultsTime frame: Day 180

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Unidad de Investigación en Salud (UIS)

    Chihuahua City, Mexico

  • Hospital "Dr. Angel Leaño"

    Guadalajara, Mexico

  • Instituto Dermatologico Jalisciense

    Guadalajara, Mexico

  • Centro Dermatologico Pascua

    Mexico City, Mexico

  • CIF-BIOTEC Medica Sur.

    Mexico City, Mexico

  • IMIC

    Mexico City, Mexico

  • Hospital Universitario Dr. José Eleuterio González

    Monterrey, Mexico

  • MIRC / OCA Hospital

    Monterrey, Mexico

  • ISSEMYM

    Toluca, Mexico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.